Activation of natriuretic peptides and the sympathetic nervous system following Roux-en-Y gastric bypass is associated with gonadal adipose tissues browning

Molecular Metabolism

Volumn 4, Issue 5, 2015, Pages 427-436

  Neinast, Michael D ^a   Frank, Aaron P ^a,b   Zechner, Juliet F ^a   Li, Quanlin ^b   Vishvanath, Lavanya ^a   Palmer, Biff F ^a   Aguirre, Vincent ^a   Gupta, Rana K ^a   Clegg, Deborah J ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Atrial natriuretic peptide (ANP); B type natriuretic peptide (BNP); Browning; High fat diet (HFD); Natriuretic peptide receptor; Roux en Y gastric bypass (RYGB)

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; BRAIN NATRIURETIC PEPTIDE; HORMONE RECEPTOR; LEPTIN; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR 1; NATRIURETIC PEPTIDE RECEPTOR 2; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA 3 ADRENERGIC RECEPTOR GENE; BRAIN NATRIURETIC PEPTIDE GENE; BROWN ADIPOSE TISSUE; CALORIC RESTRICTION; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; METABOLIC REGULATION; MOUSE; NATRIURETIC PEPTIDE RECEPTOR 1 GENE; NATRIURETIC PEPTIDE RECEPTOR 2 GENE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SYMPATHETIC TONE; UCP1 GENE; WEIGHT REDUCTION; WILD TYPE;

MUS;

EID: 84933671853     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.02.006     Document Type: Article

References (48)

1. Sanchis P., Frances C., Nicolau J., Rivera R., Fortuny R., Julian X., et al. Cardiovascular risk profile in Mediterranean patients submitted to bariatric surgery and intensive lifestyle intervention: impact of both interventions after 1 year of follow-up. Obesity Surgery 2014.
2. Bielefeldt K. Bariatric surgery versus intensive medical therapy for diabetes. The New England Journal of Medicine 2014, 371(7):681-682.
3. Adams T.D., Davidson L.E., Litwin S.E., Kolotkin R.L., LaMonte M.J., Pendleton R.C., et al. Health benefits of gastric bypass surgery after 6 years. The Journal of the American Medical Association 2012, 308(11):1122-1131.
4. Keating C.L., Dixon J.B., Moodie M.L., Peeters A., Playfair J., O'Brien P.E. Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care 2009, 32(4):580-584.
5. Surgery, A.S.f.M.a.B., Bariatric Surgery Procedures.
6. Lips M.A., Van Klinken J.B., van Harmelen V., Dharuri H.K., t Hoen P.A., Laros J.F., et al. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes mellitus. Diabetes Care 2014.
7. Wickremesekera K., Miller G., Naotunne T.D., Knowles G., Stubbs R.S. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obesity Surgery 2005, 15(4):474-481.
8. Laferrere B., Teixeira J., McGinty J., Tran H., Egger J.R., Colarusso A., et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism 2008, 93(7):2479-2485.
9. van Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J.M., Kemerink G.J., Bouvy N.D., et al. Cold-activated brown adipose tissue in healthy men. The New England Journal of Medicine 2009, 360(15):1500-1508.
10. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., et al. Functional brown adipose tissue in healthy adults. The New England Journal of Medicine 2009, 360(15):1518-1525.
11. Cypess A.M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A.B., et al. Identification and importance of brown adipose tissue in adult humans. The New England Journal of Medicine 2009, 360(15):1509-1517.
12. Harms M., Seale P. Brown and beige fat: development, function and therapeutic potential. Nature Medicine 2013, 19(10):1252-1263.
13. Ricquier D. Uncoupling protein 1 of brown adipocytes, the only uncoupler: a historical perspective. Frontiers in Endocrinology (Lausanne) 2011, 2:85.
14. Wang Q.A., Scherer P.E., Gupta R.K. Improved methodologies for the study of adipose biology: insights gained and opportunities ahead. The Journal of Lipid Research 2014, 55(4):605-624.
15. Kajimura S., Saito M. Anew era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis. Annual Review of Physiology 2014, 76:225-249.
16. Yoneshiro T., Aita S., Matsushita M., Kameya T., Nakada K., Kawai Y., et al. Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men. Obesity (Silver Spring) 2011, 19(1):13-16.
17. Bordicchia M., Liu D., Amri E.Z., Ailhaud G., Dessi-Fulgheri P., Zhang C., et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. Journal of Clinical Investigation 2012, 122(3):1022-1036.
18. Changchien E.M., Ahmed S., Betti F., Higa J., Kiely K., Hernandez-Boussard T., et al. B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss. Surgical Endoscopy 2011, 25(7):2338-2343.
19. Mossenbock K., Vegiopoulos A., Rose A.J., Sijmonsma T.P., Herzig S., Schafmeier T. Browning of white adipose tissue uncouples glucose uptake from insulin signaling. PLoS One 2014, 9(10):e110428.
20. Maggard M.A., Yermilov I., Li Z., Maglione M., Newberry S., Suttorp M., et al. Pregnancy and fertility following bariatric surgery: a systematic review. The Journal of the American Medical Association 2008, 300(19):2286-2296.
21. Zechner J.F., Mirshahi U.L., Satapati S., Berglund E.D., Rossi J., Scott M.M., et al. Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans. Gastroenterology 2013, 144(3):580-590. e587.
22. Bookout A.L., Mangelsdorf D.J. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nuclear Receptor Signaling 2003, 1:e012.
23. Colman E., Katzel L.I., Rogus E., Coon P., Muller D., Goldberg A.P. Weight loss reduces abdominal fat and improves insulin action in middle-aged and older men with impaired glucose tolerance. Metabolism 1995, 44(11):1502-1508.
24. Bays H.E., Toth P.P., Kris-Etherton P.M., Abate N., Aronne L.J., Brown W.V., et al. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. The Journal of Clinical Lipidology 2013, 7(4):304-383.
25. Seale P., Conroe H.M., Estall J., Kajimura S., Frontini A., Ishibashi J., et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. Journal of Clinical Investigation 2011, 121(1):96-105.
26. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiological Reviews 2004, 84(1):277-359.
27. Sengenes C., Berlan M., De Glisezinski I., Lafontan M., Galitzky J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB Journal 2000, 14(10):1345-1351.
28. Sengenes C., Zakaroff-Girard A., Moulin A., Berlan M., Bouloumie A., Lafontan M., et al. Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2002, 283(1):R257-R265.
29. Shin A.C., Zheng H., Townsend R.L., Patterson L.M., Holmes G.M., Berthoud H.R. Longitudinal assessment of food intake, fecal energy loss, and energy expenditure after Roux-en-Y gastric bypass surgery in high-fat-fed obese rats. Obesity Surgery 2013, 23(4):531-540.
30. Dirksen C., Jorgensen N.B., Bojsen-Moller K.N., Kielgast U., Jacobsen S.H., Clausen T.R., et al. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. International Journal of Obesity (London) 2013, 37(11):1452-1459.
31. Nestoridi E., Kvas S., Kucharczyk J., Stylopoulos N. Resting energy expenditure and energetic cost of feeding are augmented after Roux-en-Y gastric bypass in obese mice. Endocrinology 2012, 153(5):2234-2244.
32. Lutz T.A., Bueter M. The physiology underlying Roux-en-Y gastric bypass: a status report. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2014, 307(11):R1275-R1291.
33. Bueter M., Lowenstein C., Olbers T., Wang M., Cluny N.L., Bloom S.R., et al. Gastric bypass increases energy expenditure in rats. Gastroenterology 2010, 138(5):1845-1853.
34. Fried M., Ribaric G., Buchwald J.N., Svacina S., Dolezalova K., Scopinaro N. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies. Obesity Surgery 2010, 20(6):776-790.
35. Rubino F., Gagner M., Gentileschi P., Kini S., Fukuyama S., Feng J., et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. The Annals of Surgery 2004, 240(2):236-242.
36. Shi Z., Brooks V.L. Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of estrogen. The Journal of Physiology 2014.
37. Munzberg H., Morrison C.D. Structure, production and signaling of leptin. Metabolism 2015, 64(1):13-23.
38. Qiu Y., Nguyen K.D., Odegaard J.I., Cui X., Tian X., Locksley R.M., et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014, 157(6):1292-1308.
39. Bartness T.J., Liu Y., Shrestha Y.B., Ryu V. Neural innervation of white adipose tissue and the control of lipolysis. Frontiers in Neuroendocrinology 2014, 35(4):473-493.
40. Potter L.R., Yoder A.R., Flora D.R., Antos L.K., Dickey D.M. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. The Handbook of Experimental Pharmacology 2009, (191):341-366.
41. Sengenes C., Bouloumie A., Hauner H., Berlan M., Busse R., Lafontan M., et al. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. The Journal of Biological Chemistry 2003, 278(49):48617-48626.
42. Miyashita K., Itoh H., Tsujimoto H., Tamura N., Fukunaga Y., Sone M., et al. Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 2009, 58(12):2880-2892.
43. Meirhaeghe A., Sandhu M.S., McCarthy M.I., de Groote P., Cottel D., Arveiler D., et al. Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Human Molecular Genetics 2007, 16(11):1343-1350.
44. Inokuma K., Okamatsu-Ogura Y., Omachi A., Matsushita Y., Kimura K., Yamashita H., et al. Indispensable role of mitochondrial UCP1 for antiobesity effect of beta3-adrenergic stimulation. The American Journal of Physiology - Endocrinology and Metabolism 2006, 290(5):E1014-E1021.
45. Cannon B., Nedergaard J. Metabolic consequences of the presence or absence of the thermogenic capacity of brown adipose tissue in mice (and probably in humans). International Journal of Obesity (London) 2010, 34(Suppl 1):S7-S16.
46. Fisher F.M., Kleiner S., Douris N., Fox E.C., Mepani R.J., Verdeguer F., et al. FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes & Development 2012, 26(3):271-281.
47. Fu T., Seok S., Choi S., Huang Z., Suino-Powell K., Xu H.E., et al. MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Molecular and Cellular Biology 2014, 34(22):4130-4142.
48. Jansen P.L., van Werven J., Aarts E., Berends F., Janssen I., Stoker J., et al. Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery. Digestive Diseases 2011, 29(1):48-51.